InsidersTradesSigma
基于 11 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the complete record of transactions filed by 강종구, 管理人员. Officer active across 2 companies, notably 바이오톡스텍. Cumulatively, 32 disclosures have been recorded. Regulator: DART (FSS). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
32 条申报中的 25 条
강종구 is a director and a declarant linked to 바이오톡스텍, where he is identified as a large shareholder. The record shows 15 filings in total, and for the sampled recent filings the period runs from 2022-03-28 to 2026-07-29; the modal transaction nature is Purchase.